Breast cancer pathogenesis is influenced by various molecular and environmental risk factors. It begins through the mutation of oncogenes, tumor suppressor genes, and dysregulation of key cell ...

Molecular testing is crucial for precision oncology in AML and MDS, but barriers hinder its routine integration. The study analyzed genomic data from 2018 to 2023, focusing on testing rates, types, ...

A novel radiopharmaceutical therapy approach that targets fibroblast activation protein (FAP)—which is highly expressed in ...

Targeted therapy is a form of precision medicine. We’ve been moving away over the last 10-15 years from conventional chemotherapy, which can be effective against certain cancers. But it carries lots ...

Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group Knowledge on how molecular ...

Chronic lymphocytic leukaemia, which is the most reported type of leukaemia in adults. In the past ten years. There have been advances in medical research that have informed changes in how healthcare ...

An international study led by a scientist at the University of Ottawa Faculty of Medicine is opening new frontiers in the ...

Three Versus 6 Months of Adjuvant Oxaliplatin-Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial Overall, 210 ...

Metastatic melanoma, also known as stage IV melanoma, is a type of skin cancer that spreads to other parts of the body. It is one of the most aggressive forms of skin cancer, with current ...

A lot has changed about the cancer treatment methods over the past few years. Doctors are increasingly paying attention to personalized medicine. And targeted therapy is one of the breakthroughs in ...